1
Regulating transgenic technology in China:Law, regulation, and public policy
Yinliang Liu
Dr. of Laws, M.S. (Biology), Associate Professor
Vice Director, Institute of IP Law
Director, Bio-Law Research Center
China University of Political Science and Law3 December 2007
2
Outline
Administrations of transgenic technologies Laws and regulations involving agricultural GMOs Laws and regulations involving medical transgenic technolo
gies Conclusion
3
I. Administrations of transgenic technologies Ministry of Science and Technology: policy making, R&D Ministry of Commerce: GM trade Ministry of Health: GM food, medicine Ministry of Agriculture: GM crops State Forestry Administration: GM trees State Environmental Protection Administration: biosafety State Food and Drug Administration: GM food, medicine State Administration of Quality Supervision, Inspection, a
nd Quarantine: inspection & quarantine of GM products SIPO/MOA/SFA: IP issues, patent and plant varieties
National Natural Science Foundation: R&D support CAS, CAAS, CAMS: R&D
4
# Different concepts
Law: promulgated by National People’s Congress or its Standing Committee
Regulation: State Council (Administrative) rule: ministries
Local regulation: local people’s congress Local rule: local government
Policy document
5
II. Laws and regulations involving agricultural GMOs
6
Laws and regulations may involve Ag GMOs Food Hygiene Law (1995) Forest Law (1998 revised) Environmental Protection Law (1999) Marine Environmental Protection Law (2000) Seed Law (2000) Patent Law (2000 revised) Drug Administration Law (2001 revised) Grassland Law (2002 revised) Wild Animal Protection Law (2004 revised) Animal Husbandry Law (2005)
Regulation on Protection of Nature Reserves (1994) Regulation on Protection of Wild Plants (1997) Regulation on Protection of New Varieties of Plant (1997)
7
Regulations & rules governs directly Ag GMO
Administrative Measures for Safety of Genetic Engineering (1993, NCST/MOST)
Regulation on Safety Administration of Agricultural GMOs (2001, State Council)
Administrative Measures for Safety Assessment of Agricultural GMOs (2002, MOA)
Administrative Measures for Safety of Imported Agricultural GMOs (2002, MOA)
Administrative Measures for Labelling Agricultural GMOs (2002, MOA)
Administrative Measures for Hygiene of GM Food (2002, MOH)
Administrative Measures for Inspection and Quarantine of GM Products (2004, State Administration of Quality Supervision, Inspection and Quarantine)
8
Definition and scope of Ag GMOs
Those transgenic animals, plants, microbes, whose genomes have been modified by genetic engineering
Their products The processed products derived directly from the
m, such as, herbicide, animal medicine, fertilizer, food, feed, or their additives
9
Activities involving Ag GMOs
Manufacture, process, transport, stock, sale. The responsbile parties shall maintain necessary conditions, e.g.,
Manufacturer of GMOs shall: (1) get safety license from MOA; (2) establish files to record information, including the trans
ferred gene and its resource, transgenic method, manufacturing place, flow of the reproductive materials of GMOs;
(3) report information to administration regularly; (4) furnish necessary safety control measures during tran
sportation
10
Licenses of Ag GMOs (2002-2005)
Plants Animals Microbes TotalExperiment 1 4 0 5Pilot test 305 5 146 456 En. release 147 0 64 211Production test 143 0 38 181Safety license 379 0 45 424
- Research and Biosafety Regulation of Agricultural GMOs in China (July 2006)
11
Import of Ag GMOs
Comply essentially with the Biosafety Protocol GMO could be used: for research, test, production, process
ing, products Safety license from MOA Simplified procedure: first approval, then simplified
12
License of imported Ag GMOs as processing materials
From 2004 - 2006, 36 licenses Four kinds of GMO: cotton, soybean, corn, rapeseed Bayer CropScience: 15 licenses, 3 GMOs Monsanto: 14 licenses, 4 GMOs Syngenta: 4 licenses, 1 GMO Du Pont/Dow Agrosciences Cbiilia: 3 licenses, 1 GMO
13
Labeling Ag GMOs
Compulsory label: listed GMOs by MOA, 17 kinds of products belong to 5 varieties of GMOs (soybean, corn, rapeseed, cotton, tomato)
Voluntary label: for GMOs not listed by MOA Labeling could be one of the followings: (1) “transgenic (organism or product)”; (2) “transgenic (organism) processed product”; (3) “this product is processed from transgenic (organis
m), but it now does not have any transgenic components”
14
Labels shall be in standard Chinese, marked apparently, fixed to products or their package or by plate
Labels shall be approved before use by administration of agriculture at local level; labels of the imported GMOs shall be approved by MOA
Negative label, i.e., “GM free product”, has not been encouraged or prohibited
15
GM food
GM food includes food or its additives, made of/from GMO or its processed products or the materials derived from them
Must be safe, have nutrient value not less than its non-GMO equivalence
Principle of assessment of GM food: substantially equivalent; case-by-case
All GM food must be labeled: in either “transgenic (organism) food”, or, “made of the transgenic (organism) food”, or, additionally, “persons allergic to (certain) food should be alerted”
16
III. Laws and regulations involving medical transgenic technologies
17
Medical applications of transgenic technologies
GMOs as medicine or vaccine Recombinant proteins Gene therapy Stem cell culture for healthy cell, tissue and organ Therapy clone Xenotransplantation Other medical processes etc
18
GMOs or GM products as medice or involved in medical processes
Shall register at SFDA and have a license for clinical use Must comply with the Drug Administration Law and its regul
ation Safety and efficacy must be guaranteed
--- Administrative Measures for Safety of Genetic Engineering (1993, NCST/MOST)
19
Medical laws Law on Mother and Infant Healthcare (1994) Law on Blood Donation (1997) Law on Medical Practioners (1998) Drug Administration Law (2001 revised) Law on Prevention and treatment of Occupational Disease
s (2001 revised) Law on Population and Family Planning (2001 revised) Law on Prevention and Treatment of Infectious Diseases (2
004 revised)
20
Medical regulations
Regulation on Administration of Family Planning Technical Services (2001)
Regulation on Treatment of Medical Malpractices (2002) Regulation on Public Health Emergencies (2003) Regulation on Prevention and Treatment of HIV/AIDS (200
6) Regulation on Transplantation of Human Organs (2007)
21
Related rules by MOH
Measures on Administration of Assistant Human Reproduction Technique (2001)
Measures on Administration of Human Sperm Banks (2001)
Measures on Administration of Prenatal Diagnosis Technology (2002)
Provisional Measures on Administration of Organ Transplantation Technique in Clinical Application (2006)
Interim Measures on Ethical Review of Biomedical Researches Involving Human Subjects (2007)
22
Technical standards by MOH & SFDA
Key Elements of Quality Control of Clinical Tests Regarding Human Somatic Cell Therapy and Gene Therapy (MOH, 1993)
Administrative Standard for Clinical Tests of Medicine, State Food and Drug Administration (SFDA, 1999)
Principles of Guideline on Application of Clinical Tests of Human Gene Therapy, Annex No.9 to the Measures for Review of New Biological Products (SFDA, 1999)
23
Technical Norms for Assisted Reproductive Technologies (2003)
Basic Criteria and Technical Norms for Human Sperm Banks (2003)
Administrative Norms for Technology of Transplantation of Unrelated Hematopoietic Stem Cells (2006)
Administrative Norms for Technology of Collection of Unrelated Hematopoietic Stem Cells (2006)
24
What the Measures and/or Standards say
# e.g., Technical Standard of Assisted Reproductive Technology by MOH demands technicians conducting ART shall:
Obey strictly the population and family planning laws and regulations
Obey strictly the principles of informed consent and informed choice
Respect patients’ right of privacy
25
The following activities prohibited
Sex selection without medical evidences Nuclear transplantation for treatment of infertility Mixing human gametes with non-human ones Transplantation into human of non-human gametes or e
mbryos; and, vice versa Genetic maneuvers of human gametes, fertilized eggs,
or embryos for purpose of reproduction
26
Additionally, prohibited
Combination of gametes with close kinship Without patients’ informed and voluntary consent, transfe
ring gametes, fertilized eggs or embryos to others or for scientific research
Research on chimera of human & non-human embryos Human clone During a same therapeutic period, using gametes and fer
tilized eggs not from the same man & woman
27
What have and lack
It seems almost every aspect regarding biotechnological manipulations in medicine has been in the rules (administrative measures) or technical standards, which is being ready to protect the right of human subjects and the public welfare
However, it is noticed more contents exist in the technical standards or administrative measures that generally lack legal powers, and fewer contents in the relevant laws and regulations which may prescribe civil or criminal liabilities and damages
28
IV. Conclusion
It is showed China has been following the world actively to ensure both safety (food, medicine, environment/ecology) and benefit of transgenic technologies
Till present, a framework has been established in China for regulating transgenic technologies in both agriculture and medicine
The framework may reflect an approach mixed with elements adopted in EU and USA, respectively
However, it may still lack a harmonized system of laws and regulations for all kinds of GMOs and transgenic activities
Further biotechnology legislation is needed